Coronary heart disease and chronic obstructive pulmonary disease prevalence and temporal trends among United States adults: a national population-based study - Report - MDSpire
Advertisement
Coronary heart disease and chronic obstructive pulmonary disease prevalence and temporal trends among United States adults: a national population-based study
Clinical Report: Prevalence and Trends of Coronary Heart Disease and COPD
Background
Coronary heart disease and chronic obstructive pulmonary disease are significant contributors to morbidity and mortality worldwide. The co-existence of these conditions complicates clinical management and increases the healthcare burden, particularly among aging populations. Understanding the prevalence and risk factors associated with CHD-COPD co-morbidity is crucial.
Data Highlights
No statistically significant increase in CHD-COPD co-morbidity prevalence was observed from 2020 to 2024 (p = 0.072).
Key Findings
CHD-COPD co-morbidity prevalence remained stable at approximately 0.35%–0.43% annually.
Older age was independently associated with higher odds of co-morbidity (aOR: 1.004; p < 0.0001).
Current and former smokers had approximately 5–6 times higher odds of CHD-COPD co-morbidity.
Socioeconomic factors such as lower income and Southern residence were significant predictors.
Age, sex, body mass index, race/ethnicity, geographical region, smoking status, insurance status, income, and educational attainment were strong independent predictors of co-morbidity.
Clinical Implications
Healthcare providers should consider the significant predictors of CHD-COPD co-morbidity when assessing patients, particularly focusing on older adults and those with a history of smoking. Integrated management strategies addressing shared risk factors may improve outcomes for these patients.
Conclusion
The stable prevalence of CHD-COPD co-morbidity indicates the importance of understanding sociodemographic disparities.
